Analysis of Ischemia-Modified Albumin (IMA) and Coagulation Parameters in Patients with SARS-CoV-2 Pneumonia

Background: Coronavirus disease 2019 (COVID-19) is a systemic disease which causes an increased inclination to thrombosis by leading to coagulation system activation and endothelial dysfunction. Our objective in this study is to determine whether ischemia-modified albumin (IMA) can be used as a new...

Descripción completa

Detalles Bibliográficos
Autores principales: Saglam, Emel, Sener, Gulsen, Bayrak, Tulin, Bayrak, Ahmet, Gorgulu, Numan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342497/
https://www.ncbi.nlm.nih.gov/pubmed/37445341
http://dx.doi.org/10.3390/jcm12134304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342497/
https://www.ncbi.nlm.nih.gov/pubmed/37445341
http://dx.doi.org/10.3390/jcm12134304

Ejemplares similares